Enhancing Autoregulation-guided Blood Pressure Management after Large-vessel Ischemic Stroke
Pwint Thinzar1, Sithmi Jayasundara1, David Vargas Estrella1, Kaitlyn Stoehr1, Santiago Ortega Gutierrez2, Nils Petersen1
1Yale University, 2University of Iowa
Objective:
To assess for hemispheric differences in autoregulation-based blood pressure (BP) targets and evaluate the benefits of incorporating data from the unaffected hemisphere.
Background:
Continuous monitoring of regional cerebral oxygenation saturation (rSO2) in the affected hemisphere is commonly used to calculate autoregulation-based individualized BP targets for acute ischemic stroke patients. However, there is uncertainty regarding the applicability of these same BP targets to the unaffected cerebral hemisphere.
Design/Methods:
All patients underwent continuous physiologic data recordings for 24 hours following thrombectomy. Cerebral autoregulation was calculated as a moving correlation coefficient between arterial BP and near-infrared spectroscopy-based rSO2. The resulting index was used to determine the mean arterial pressure at which autoregulation was most preserved (MAPopt). ANOVA was conducted to compare MAPopt values between the affected side, the unaffected side, and an average across both hemispheres. Reliability was assessed using Bland-Altman and intraclass correlation coefficient (ICC) analyses. Additionally, the time to achieve the first personalized BP target and the percentage of MAPopt availability were evaluated.
Results:
In total, 189 patients (mean age 70.9, mean NIHSS 13.7, left/right LVO 50.8%/49.2%) were included in the study. The mean MAPopt for the affected side was 91.3mmHg, compared to 91.2mmHg for the unaffected side (p>0.05). Bland-Altman analysis indicated a minimal MAPopt bias, showing a discrepancy of 0.06mmHg for averaged vs. affected side and 0.19mmHg for averaged vs. unaffected side, along with an excellent ICC of 0.96 (95%CI 0.95-0.97, p<0.05). Using an average across both hemispheres increased the availability of MAPopt to 85.5%, versus 78.1% and 75.1% when considering affected and unaffected sides respectively. Moreover, the time to reach the first personalized BP target was shorter (94 minutes for averaged, compared to 124 and 125 minutes for affected and unaffected sides, respectively).
Conclusions:
Personalized BP targets are consistent across hemispheres. Using data from both hemispheres decreases delays and improves MAPopt availability.
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.